Article info
PDFPaper
Bone marrow transplantation in the prevention of intellectual disability due to inherited metabolic disease: ethical issues
- Pekka Louhiala, Vuorikatu 17 as 3, 13100 Hämeenlinna, Finland; pekka.louhiala{at}helsinki.fi
Citation
Bone marrow transplantation in the prevention of intellectual disability due to inherited metabolic disease: ethical issues
Publication history
- Received September 24, 2008
- Revised March 10, 2009
- Accepted April 15, 2009
- First published June 30, 2009.
Online issue publication
June 30, 2009
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
2009 BMJ Publishing Group & Institute of Medical Ethics
Other content recommended for you
- Clinical course of sly syndrome (mucopolysaccharidosis type VII)
- Ethical issues related to the access to orphan drugs in Brazil: the case of mucopolysaccharidosis type I
- Haemopoietic stem cell transplantation for genetic disorders
- Mucopolysaccharidosis type I disguised as rickets
- Kenneth Hugh-Jones
- Cardiac issues in adults with the mucopolysaccharidoses: current knowledge and emerging needs
- Hurler syndrome (Mucopolysaccharidosis type I)
- Mucopolysaccharidosis type IVA (Morquio A): a close differential diagnosis of spondylo-epiphyseal dysplasia
- Psychopharmacological treatment of behavioural problems in Sanfilippo syndrome
- Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis